Clinical Trial Update: Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a thymalfasin-based PRaG mode in advanced refractory solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Thymalfasin-based PRaG mode (thymalfasin-based PRaG mode)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Advanced Solid Tumor, Refractory Tumor | Phase 2 | Status: UNKNOWN